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Introduction
lthough many important discoveries have
been made in the study of cognition, neuroscience, and
mental illness, there is growing frustration with the rate
of translation of these efforts into understanding of eti-
ological foundations and new treatments. One important
contributing factor to the slow rate of progress is the
widespread reliance of research projects on categorical,
symptom-based diagnostic systems such as the
Diagnostic and Statistical Manual of Mental Disorders
(DSM) and the International Classification of Diseases
(ICD).Although these systems have contributed greatly
to the reliability of psychiatric diagnoses made for
research and clinical purposes, their categories and cri-
teria were formulated before modern neuroscience, and
the validity of the diagnoses is accordingly questionable.
Progress toward understanding and treating mental ill-
ness has been hindered by the scientific focus on diag-
noses that do not reflect the organization of neural cir-
cuits and their associated behaviors. For cognitive
processes, as with other areas of research on mental dis-
orders, burgeoning knowledge about fundamental pro-
grams of behavior, and their implementing neurobio-
logical circuitry, mandates a shift in thinking about the
classification of psychiatric disorders.
State of the art
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Current diagnostic systems for mental disorders were
established before the tools of neuroscience were avail-
able, and although they have improved the reliability of
psychiatric classification, progress toward the discovery of
disease etiologies and novel approaches to treatment and
prevention may benefit from alternative conceptualiza-
tions of mental disorders. The Research Domain Criteria
(RDoC) initiative is the centerpiece of NIMH’s effort to
achieve its strategic goal of developing new methods to
classify mental disorders for research purposes. The RDoC
matrix provides a research framework that encourages
investigators to reorient their research perspective by tak-
ing a dimensional approach to the study of the genetic,
neural, and behavioral features of mental disorders.
RDoC’s integrative approach includes cognition along with
social processes, arousal/regulatory systems, and negative
and positive valence systems as the major domains,
because these neurobehavioral systems have all evolved
to serve the motivational and adaptive needs of the
organism. With its focus on neural circuits informed by the
growing evidence of the neurodevelopmental nature of
many disorders and its capacity to capture the patterns of
co-occurrence of behaviors and symptoms, the RDoC
approach holds promise to advance our understanding of
the nature of mental disorders.   
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To encourage scientists to break free of categorical diag-
nostic constraints and realign mental illness research
with the knowledge gained from the accelerating pace
of findings regarding the relationship of genetic and
neural factors to behavior, the National Institute of
Mental Health has initiated the Research Domain
Criteria (RDoC) project. This initiative represents the
implementation of Strategy 1.4 of the NIMH Strategic
Plan, to “Develop, for research purposes, new ways of
classifying mental disorders based on dimensions of
observable behavior and neurobiological measures.
1”
The long-term goals of the project are to validate tasks
for use in clinical trials, identify new targets for treat-
ment development, define meaningful clinical subgroups
for the purpose of treatment selection, and provide a
pathway by which research findings can be translated
into changes in clinical decision making. In the near
term, efforts under the RDoC initiative will focus on
identifying broad domains of functioning and their con-
stituent dimensional constructs, developing reliable and
valid measures across a range of units of analysis for
each construct, and supporting studies to determine the
full range of variation present in clinical and nonclinical
populations with respect to the various domains. As dis-
cussed in more detail below, the RDoC organization has
been represented as a two-dimensional matrix with
domains (and constituent constructs) as the rows, and
the various units of analysis as the columns.
Two developments in recent years helped to “set the
stage” for the RDoC project to germinate and gain
momentum. First, the revision of the DSM in prepara-
tion for the publication of the fifth edition stimulated
discussions about the role of neuroscience in disease
classification and the various reasons why neuroscience
has not yielded progress commensurate with the
promise of new technologies for understanding brain
function.
2The concern was raised that perhaps, through
decades of focus on refinement, revision, and expansion
of DSM diagnoses, diagnostic categories that precede
modern neuroscience have become reified; in turn, this
situation has impeded progress in the search for behav-
ioral, neural, and genetic signals that will allow an under-
standing of etiology and guide the development of novel
treatments.
3 These discussions provided a backdrop for
the consideration of alternative systems for classifying
mental disorders.
Secondly, the conceptualization and implementation of
RDoC was influenced by the NIMH’s Measurement and
Treatment Research to Improve Cognition in
Schizophrenia (MATRICS) initiative. The primary goals
of the MATRICS project were to develop a consensus
battery for measuring cognition in schizophrenia, to
develop guidelines for the design of trials investigating
cognition-enhancing medications based on consensus
among the pharmaceutical industry, academia, NIMH,
and the US Food and Drug Administration, and to assist
NIMH in shaping its research priorities in this area.
4 A
related project, the Cognitive Neuroscience Treatment
Research to Improve Cognition in Schizophrenia
(CNTRICS) initiative, grew out of the “New
Approaches to Cognition” meeting conducted under
MATRICS. CNTRICS was focused on translating the
knowledge and methods of cognitive, social, and affec-
tive neuroscience into a set of cognitive systems and
processes to be targeted for treatment and measurement
using standardized, psychometrically sound measures in
behavioral as well as neuroimaging studies.
5 Although
both MATRICS and CNTRICS focused on one clinical
concern (cognition in schizophrenia), their rigorous
focus and collaborative process—distilling a large and
nuanced literature to a manageable number of well-
defined domains, followed by standardization of mea-
surement—provided a template for the processes by
which RDoC has advanced. In a parallel but more com-
prehensive initiative, RDoC aims to define major
domains for the study of mental illness and validate
them using optimal genetic, neuroscientific, physiologi-
cal, behavioral, and self-report measures.
The RDoC matrix
The RDoC scheme can be represented as a two-dimen-
sional matrix (Table I). The rows represent the “dimen-
sions of observable behavior and neurobiological mea-
sures” specified in Goal 1.4 of the NIMH Strategic Plan.
These dimensions are referred to as “constructs” to rep-
resent their status as concepts regarding brain organiza-
tion and functioning that evolve with advances in
research. In turn, constructs are grouped under five
superordinate domains of activity, which reflect a con-
ceptual typology of functions as well as empirical rela-
tionships among activity in related brain circuits. 
The columns of the matrix represent various units (or
levels) of analysis that can be used to measure the var-
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emphasize the integrative approach. The units of analy-
sis are as follows: genes, molecules, cells, circuits, phys-
iology, behavior, and self-report. Genes, molecules, and
cells are self-apparent (although in many cases, direct
assessment of molecules and cells in functioning
humans remains problematic). The “Circuits” unit of
analysis refers to measures that can index the activity
of neural circuits, either through functional neu-
roimaging or through recordings previously validated
as circuit indices (eg, fear-potentiated startle).
“Physiology” refers to well-established measures that
have been validated in assessing various constructs, but
that do not measure circuit activity directly (eg, heart
rate, cortisol). “Behavior” may refer either to system-
atically observed behavior or to performance on a
behavioral task such as working memory. There is also
a separate column for paradigms, in which scientific
tasks that are especially useful for the study of the con-
struct are noted. 
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Units of analysis
Domains/constructs Genes Molecules Cells Circuits Physiology Behavior Self-reports Paradigms
Negative valence systems
Active threat (“fear”)
Potential threat (“anxiety”)
Sustained threat
Loss
Frustrative nonreward
Positive valence systems
Approach motivation
Initial responsiveness to reward
Sustained responsiveness to reward
Reward learning
Habit
Cognitive systems
Attention
Perception
Working memory
Declarative memory
Language behavior
Cognitive (effortful) control
Systems for social processes
Imitation, theory of mind
Social dominance
Facial expression identification
Attachment/separation fear
Self-representation areas
Arousal/regulatory systems
Arousal and regulation (multiple)
Resting state activity
Table I. Research Domain Criteria Matrix. “Circuits” can refer to measurements of particular circuits as studied by neuroimaging techniques, and/or
other measures validated by animal models or functional neuroimaging (eg, emotion-modulated startle, event-related potentials). “Physiology”
refers to measures that are well-established indices of certain constructs, but that do necessarily not tap circuits directly (eg, heart rate, event-
related potentials). “Behavior” can refer variously to behavioral tasks (eg, a working memory task), or to behavioral observations. “Self-reports”
refer to interview scales, questionnaires, or other instruments that may encompass normal-range and/or abnormal aspects of the dimension
of interest. It should be noted that the constructs for the cognitive systems domain were adapted from those identified through the CNTRICS
effort. The Systems for Social Processes and Arousal/Regulatory domains and associated constructs are considered to be in draft form pend-
ing the workshops to be completed in 2012.
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are populated by research findings. Overall, the RDoC
matrix structure is intended to facilitate integration of
existing research findings and foster the identification of
gaps in the knowledge base that represent promising
areas for integrative research.
How will the RDoC matrix actually function as a classi-
fication system for experimental purposes? For per-
spective, it may be pointed out that the current system
imposes three constraints upon the independent variable
(ie, group classification) in psychiatric studies: first,
symptoms are the unit of analysis that must be utilized;
second, particular constellations of symptoms must be
employed (ie, the DSM polythetic criteria or their ICD
equivalents); and third, the symptoms must be employed
(with rare exceptions) simply to render a binary, diag-
nosis present/absent decision rather than being quanti-
fied in any way. RDoC is intended to free investigators
from these constraints. An element from any unit of
analysis may be the independent variable. In a study of
working memory, performance on a working memory
task could be the independent variable (possibly strati-
fied by particular genetic polymorphisms), and activa-
tion of relevant working memory areas (as measured by
fMRI) and real-world functional capacity might be
dependent variables. As another example, patients pre-
senting with internalizing (mood or anxiety) disorders
might be classified along a dimension of their overall
symptom reports of distress (but independent of DSM
diagnosis), and fear circuit activation in some relevant
task (eg, imagery, film clips) might be assessed in order
to test the hypotheses that increasing severity and/or
chronicity of distress are associated with hyporeactiv-
ity in fear activation circuits. In each case, the indepen-
dent variable cannot be assigned until after the experi-
mental procedures are conducted; because the
independent variable is dimensional, however, this does
not necessarily pose problems in statistical power or
matching subjects in groups. As these examples imply,
the choice of which units of analysis to use as indepen-
dent and dependent variables depends upon the
research question.
Particularly in the early phases of studies using the
RDoC approach, it may be heuristic for investigators to
report the number of participants in study samples who
meet diagnostic criteria for various DSM primary diag-
noses in order to facilitate comparisons with traditional
and RDoC classification. However, it should be noted
that one major emphasis of Strategic Aim 1.4 is to delin-
eate the entire range of a particular dimension, notably
including patients who fall short of traditional diagnos-
tic criteria or who may have an NOS (Not Otherwise
Specified) diagnosis. Thus, including only those subjects
who meet criteria for designated DSM/ICD disorders
(even if more than one) is not a wholly satisfactory
approach in the RDoC perspective. One of the inherent
problems with the categorical approach is that, in spite
of the acknowledged heterogeneity that is apparent in
virtually all clinical diagnoses, the consequent analysis
implicitly involves the notion of a unitary entity that has
a “point” Expected Value and “normal” variance on any
given measure. Findings of group differences then imply
that all patients are impaired compared with normal
control subjects on some measure—doubly misleading
in that: (i) at least some patients are not so impaired, and
it would be important to know why; and (ii) impairment
in patients with NOS or forme fruste conditions may be
proportionately smaller and/or less severe, and exclud-
ing these patients obscures an explication of potentially
relevant dimensions and also obviates attention to clin-
ically relevant dysfunction. 
A commonly asked question is whether including
patients from widely disparate diagnoses (eg, a working
memory study including patients with primary diag-
noses of psychotic disorders, internalizing disorders, and
externalizing disorders) would result in such excessive
variance as to be meaningless. Initially, at least, this
appears to be a legitimate concern. The typical situation
would be that patients presenting for treatment at a
given type of clinic—psychotic disorders, anxiety/mood
disorders—would represent the sampling frame for a
given study, thus maximizing relevant variance while
avoiding “apples versus oranges” comparisons.
Eventually, as the circuits and measurements are better
understood, it may be productive to make these kinds
of comparisons. For instance, in recent years it has
become common to consider whether clinical depres-
sion is present as a comorbid syndrome in schizophre-
nia, for example.
6 Using symptom-based criteria, it is
difficult to know whether such symptoms are due to
“depression” pathology or to “schizophrenia” pathol-
ogy. However, measures that have been validated to
assess relevant circuit functions (whether in cognition,
reward circuit activity, or arousal systems) may provide
a heuristic to move forward in addressing such impor-
tant clinical questions. 
State of the art
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assumptions and principles
The RDoC framework has its foundation in three pos-
tulates.
7 First, mental illnesses are presumed to be disor-
ders of brain circuits. Secondly, it is assumed that the
tools of clinical neuroscience, including functional neu-
roimaging, electrophysiology, and new methods for mea-
suring neural connections can be used to identify dys-
function in neural circuits. Third, the RDoC approach
presumes that data from genetics research and clinical
neuroscience will yield biosignatures that will augment
clinical signs and symptoms for the purposes of clinical
intervention and management. 
The RDoC conceptualization includes developmental
processes and interactions with the environment as
orthogonal dimensions that should inform hypotheses and
conclusions derived from the RDoC organizational struc-
ture. Their absence from the matrix is due only to the lim-
itations of two-dimensional representation and should not
be misinterpreted as indicating that these important con-
siderations are not relevant to the RDoC research frame-
work. The importance of developmental factors (both
pre- and postnatal) is elaborated below, and recent
advances demonstrating the impact of the environment
on phenotype via epigenetic changes
8 promise new break-
throughs in our understanding of brain disorders. 
With regard to its role relative to the existing diagnostic sys-
tems, RDoC is a research framework and is not intended
to displace the DSM or ICD. It is agnostic regarding cur-
rent diagnostic categories and—in contrast to these estab-
lished diagnostic systems which are, by necessity, compre-
hensive and inclusive of a large range of disorders for which
individuals may seek professional attention—RDoC is not
intended to “cover the waterfront” of symptoms and ill-
nesses. Although relevance to psychopathology was a cri-
terion for selection of constructs, the RDoC framework is
intended to be circumscribed and sparse so that the most
important domains can be identified without generating a
multitude of constructs that have diminishing utility. As a
research framework, RDoC will incorporate procedures
for regular updates to the constructs and their defining ele-
ments resulting from ongoing research.
Current status of the RDoC initiative
The NIMH RDoC workgroup is currently in the
process of conducting a series of workshops for the
purpose of defining the initial specifications for each of
the proposed constructs. Each workshop is focused on
one domain, and is preceded by a survey of scientists
with research expertise related to the domain in order
to obtain a broad sample of opinions regarding the
domain and its related constructs. At the workshops,
invited experts from various areas that span the units
of analysis are tasked with: (i) determining the relevant
constructs for the domain; (ii) developing a definition
for each construct within the domain; and (iii) identi-
fying empirically based elements to populate the cells
of the matrix. Following each workshop, the proceed-
ings are posted on the NIMH RDoC Web site.
Continuing commentary and suggestions are welcome.
As of November 2011, the workshops for the cognitive
systems, negative valence systems, and positive valence
systems constructs have been completed; the work-
shops for the remaining constructs will be completed
by summer, 2012. In addition, interim guidance for
applicants planning to propose studies incorporating
the dimensional approach was released in March 2011,
a Request for Information to elicit feedback and com-
mentary regarding both general and specific aspects of
the RDoC approach was released in May 2011, and a
Request for Applications to encourage studies of
mechanisms that may cut across multiple traditional
diagnostic categories and evaluate the construct valid-
ity of the RDoC domains was issued by NIMH in
August 2011. These documents and additional infor-
mation regarding RDoC (including the proceedings 
of past workshops) can be viewed at
http://www.nimh.nih.gov/research-funding/rdoc/
index.shtml. 
It should be clear from this description that the RDoC
initiative is a long-term and evolving project. It is
expected that the initial framework will be largely in
place by 2012, but the iterative process of evaluating
and refining the constructs will likely occur over a 5- to
10-year timeframe, followed by ongoing modification
based on new scientific discoveries. As indicated above,
a key goal of the project is to foster development of val-
idated tasks that are feasible for use in assessing the
constructs in clinical trials or in practical clinical use.
This process may be expected to proceed gradually over
a series of years; tasks for some constructs may be avail-
able in the near future, while measures for others may
require a longer period of exploratory research and val-
idation.
RDoC in cognitive systems - Morris and Cuthbert Dialogues in Clinical Neuroscience - Vol 14 . No. 1 . 2012
33
PAGES_12_AG_1006_BA.qxd:DCNS#52  10/03/12  12:46  Page 33An integrative approach
Despite its roots in the study of cognition in schizo-
phrenia, RDoC incorporates a broad view in which cog-
nition is not considered to be “special” or distinct from
other functions, such as affective and social processes,
that are served by the brain. Similar to the concerns
about the consequences of scientific hyper-focus on cat-
egorical diagnoses, similar unintended consequences
have followed the “cognitive revolution,” including reifi-
cation of conceptual categories (eg, cognitive, affective,
social) that have “no discrete reality in the brain”.
9
Cromwell and Panksepp identify the “potentially invid-
ious consequences” of this overuse of cognition (“cog-
nitivism”), such as the tendency for “cognition” to be
“widely used as a moniker for practically all the inter-
esting functions the brain performs to facilitate behav-
ioral adaptations and survival” (p 2027). 
RDoC’s integrative approach includes cognition as part
of a conceptual framework that incorporates social
processes, arousal/regulatory systems, and negative and
positive valence systems as the major superordinate
domains, because these behavioral systems and the
neural circuits that implement them have all evolved to
serve the motivational and adaptive needs of the organ-
ism. The scientific basis for drawing brain-based bound-
aries among these domains is evolving. As the identifi-
cation of elements in the RDoC matrix proceeds and the
patterns of overlap among and specificity within differ-
ent domains become apparent, the behavioral and
neural networks with selective specialization and those
with highly integrated activities will become clearer. This
has become apparent in the early stages of the RDoC
process, as certain neural circuits have been included in
the matrix because of their specific importance to a sin-
gle construct and others (eg, circuits involving the amyg-
dala, basal ganglia) because of their involvement across
multiple constructs.
An example of how an approach consistent with the
RDoC matrix may advance research regarding cognitive
functioning in psychotic spectrum disorders is provided
in a recent paper examining a large Finnish cohort
involving probands with a schizophrenia diagnosis and
family members.
10 An unsupervised cluster analysis of
a large number of symptoms and neurocognitive mea-
sures yielded three major clusters, which appeared to
represent: (i) unaffected family members; (ii) individu-
als with core schizophrenia features; and (iii) those with
psychotic spectrum disorder involving mood symptoms
(though over half the latter cluster were diagnosed with
schizophrenia or schizoaffective disorder). Individuals
in cluster 2 were markedly impaired on all neurocogni-
tive measures, while those in cluster 3 were intermediate
between cluster 2 and unaffected family members.
Further, an association analysis indicated a significant
association between membership in cluster 2 and the
DTNBP1 gene (dysbindin), and also an association
between cluster 3 membership and the disrupted in
schizophrenia gene, DISC1. Thus, this study exemplifies
one method of approaching psychotic-spectrum disor-
ders, transcending traditional diagnostic categories to
examine empirically determined differences in cognitive
functioning and their relationship to genetic risk archi-
tectures. 
Neurodevelopment and comorbidity
By focusing on the various neural systems that serve the
adaptive needs of humans and the ways in which the
functioning of these systems can be disrupted, the
promise and potential of RDoC is to reorient the study
of mental disorders and push past the impasse that has
developed in research using more typical DSM-based
approaches.
This brain-based approach is informed by, and promises
to advance, our understanding of the neurodevelop-
mental origins of psychiatric illness. For example, there
is increasing evidence that schizophrenia, rather than
resulting from a specific set of genetic causes and neural
consequences, is instead one of several neurodevelop-
mental disorders (including bipolar disorder, autism,
attention-deficit/hyperactivity disorder, and intellectual
impairment) that have overlapping genetic contribu-
tions.
11The impacts of these neurodevelopmental anom-
alies are not limited to cognitive systems, but rather
affect widely distributed neural networks involved in a
broad range of behaviors and mental processes. One of
the important implications of this conceptualization is
that efforts to search for discrete etiologies for categor-
ical disorders are misguided. With its focus on neural cir-
cuits, RDoC will facilitate the examination of the
hypothesis that the phenotypic differences observed
among neurodevelopmental disorders can be accounted
for by variations in the nature and degree of damage to
neural circuits as well as related questions about the
ways in which developmental, compensatory, environ-
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neural circuit disruptions.
12
Related to the increased emphasis on neurodevelop-
mental underpinnings of diverse illness manifestations,
the RDoC framework encourages investigators to think
differently about comorbidity. The co-occurrence of dis-
orders and symptoms has been the focus of extensive
empirical study; however, due to the long-standing use
of categorical diagnostic distinctions in psychiatry
research, comorbidity among psychiatric disorders and
among psychiatric disorders and other types of disorders
has often been treated as experimental “noise” and nui-
sance. A psychometric perspective on diagnosis and
comorbidity
13-15 can yield new insights. Diagnoses can be
thought of as latent constructs and although the con-
structs have some internal validity,
16 this does not neces-
sarily mean that the latent construct is unidimensional.
Psychiatric diagnoses do not have explanatory power
and do not capture the complex causal relationships
within and between the genetic, neurophysiological, and
behavioral features that characterize mental illness.
13The
overlap in symptoms between diagnoses and the co-
occurrence of disorders suggest that there are “non-
symptom causal processes” (such as homeostasis) that
may, in part, explain these relationships.
14 Rather than
searching for common causes that account for the het-
erogeneous features of a categorical diagnosis, the
RDoC framework encourages investigators to consider
comorbidity from a multidimensional, empirical per-
spective that can point to new ways of understanding the
neural and genetic underpinnings of illness. 
The primary goal of RDoC’s dimensional approach and
incorporation of a range of units of analysis is not to dis-
assemble the traditional diagnostic categories, but rather
to improve our understanding of how the organization
and functioning of neural circuits result in certain behav-
iors and symptoms that naturally co-occur and to point
to new discoveries about their causal relationships.
Recent research using optogenetic approaches,
17
although presently limited to animal studies, exemplifies
this approach by demonstrating specific, causal rela-
tionships linking the effects of disease-related genes on
neural circuits and behavior. Such efforts hold promise
for the type of integrative work that will allow the field
to see a return on the investment in studies that have
demonstrated innumerable genetic, neural, and behav-
ioral differences between diagnostic groups but have
yielded few major breakthroughs in our understanding
of the causes and treatments of mental illness.
Concluding comments
The current diagnostic framework, established with the
DSM-III in 1980, has ably served both research and clin-
ical practice in the three decades that have elapsed since
its inception. It is difficult to imagine anything like the
advances that have occurred over that time without hav-
ing a common language and set of diagnostic referents.
As diagnosis across all areas of medicine accelerates into
an age of genetics and microbiology for understanding
disease trajectories, the very success of the DSM/ICD
approach is perhaps the major obstacle to considering
substantive changes. The system is completely integrated
into diagnostic codes for practice, insurance reimburse-
ments, disability judgments, clinical trials, regulatory
agency guidelines, and—particularly in the research per-
spective—grant applications and journal publications. It
is a dilemma that marked change cannot occur until a
database is available to offer new perspectives based on
genetics and neuroscience, yet such a database cannot
be built until research is conducted to explore mecha-
nisms that are independent of current categories. Such a
construction project is the goal of RDoC. If the project
is successful, future versions of the DSM and ICD—per-
haps not even DSM-6, but DSM-7—will be informed by
the findings that emerge from RDoC-guided research.
The process will not be easy or short, but already the
Institute has seen an accelerating number of RDoC-
themed grant applications. Time will tell whether such
interest is the harbinger of a paradigm shift in how the
research and practice community conceptualizes mental
disorders, but at the least, the RDoC project seems likely
to generate new perspectives regarding the relationships
of brain and behavior with respect to mental illness.  ❏
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Research Domain Criteria: sistemas 
cognitivos, circuitos neurales y dimensiones
de la conducta
Los actuales sistemas diagnósticos para los tras-
tornos mentales se establecieron antes de que
estuvieran disponibles las herramientas de las neu-
rociencias y aunque ellos han mejorado la confia-
bilidad de la clasificación psiquiátrica, el progreso
orientado al descubrimiento de las etiologías de
las enfermedades y de nuevas opciones terapéuti-
cas y de prevención puede beneficiarse a partir de
otras conceptualizaciones de los trastornos men-
tales. El proyecto Research Domain Criteria (RDoC)
es el eje central del esfuerzo del NIMH para alcan-
zar su objetivo estratégico de desarrollar nuevos
métodos de clasificación de los trastornos menta-
les para propósitos de investigación. La matriz del
RDoC proporciona una estructura de investigación
que favorece la reorientación de las perspectivas
de los investigadores de acuerdo con una aproxi-
mación dimensional en el estudio de las caracte-
rísticas genéticas, neurales y conductuales de los
trastornos mentales. El enfoque integrador del
RDoC incluye como áreas principales la cognición
junto con los procesos sociales, los sistemas de
alerta/regulación, y los sistemas de valencia nega-
tiva y positiva, dado que todos estos sistemas neu-
roconductuales han evolucionado para servir a las
necesidades de motivación y de adaptación del
organismo. El enfoque del RDoC promete avanzar
en la comprensión de la naturaleza de los trastor-
nos mentales al centrar la atención en los circuitos
neurales teniendo en cuenta la evidencia creciente
acerca de la alteración del neurodesarrollo en
muchos trastornos y su capacidad para captar los
patrones de co-ocurrencia de conductas y sínto-
mas.
Les critères de définition des domaines de
recherche : systèmes cognitifs, circuits 
neuronaux et dimensions comportementales
Les systèmes actuels de diagnostic des troubles
mentaux ont été établis avant la mise en place des
outils des neurosciences. Bien qu’ils aient amélioré
la fiabilité de la classification psychiatrique, les
progrès relatifs à la découverte de l’étiologie de la
maladie et les nouvelles approches du traitement
et de la prévention peuvent bénéficier d’autres
conceptualisations de ces troubles.  Le principe des
critères de définition des domaines de recherche
(RDoC) est le cœur des efforts du NIMH pour par-
venir à son but stratégique de développement de
nouvelles méthodes de classement des troubles
mentaux à des fins de recherche. La matrice des
RDoC fournit un cadre qui encourage les cher-
cheurs à réorienter leur perspective de recherche
selon une approche dimensionnelle de l’étude des
caractéristiques génétiques, neurales et compor-
tementales des troubles mentaux. L’approche inté-
grative des RDoC comprend la cognition accom-
pagnée des processus sociaux, des systèmes
excitation/régulation et des systèmes de valeur
positive et négative en tant que domaines princi-
paux, car ces systèmes neurocomportementaux
servent tous aux besoins adaptatifs et motivation-
nels de l’organisme. En s’intéressant aux circuits
neuronaux reposant sur la preuve croissante de la
nature neurodéveloppementale de nombreux
troubles et par sa capacité à capturer les schémas
de survenue concomitante des comportements et
des symptômes, l’approche des RDoC tient ses pro-
messes de faire progresser notre compréhension
de la nature des troubles mentaux. 
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